Insights

Gathering insights about Esper…

Similar companies to Esper

Esper Tech Stack

Esper uses 8 technology products and services including Cloudflare, CircleCI, Zendesk Chat, and more. Explore Esper's tech stack below.

Cloudflare
Content Management System
CircleCI
Continuous Integration
Zendesk Chat
Live Chat
HubSpot
Marketing Automation
PDF.js
Miscellaneous
Cloudflare Bot Management
Security
HSTS
Security
ZURB Foundation
UI Frameworks

Media & News

Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
– Presentations Examine Findings From the Pediatric Phase 2 Study, As Well As Factors Associated With Enhanced LDL-C Reductions in Adult Patients Enrolled in Clear Outcomes – – Pediatric Phase 2 Study Demonstrated Bempedoic Acid Treatment Reduced LDL-C in Children with Heterozygous Familial Hypercholesterolemia (HeFH) Congruent with Reductions in Adult Exposures – – New Analyses from CLEAR Outcomes Trial Identified Factors Associated With Enhanced LDL-C Reductions in Adult Patients – ANN ARBOR, Mich., May 13, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that two new abstracts and three encore abstracts have been accepted for presentation at the European Atherosclerosis Society (EAS) Congress 2026 taking place on May 24-27, 2026, in Athens, Greece.
May 13, 2026 | www.globenewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PFLC, ESPR, LKSB, and MKC
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating
May 05, 2026 | www.globenewswire.com
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Esperion Therapeutics, Inc. (NasdaqGM: ESPR) to funds managed by ARCHIMED. Under the terms of the proposed transaction, shareholders of Esperion will receive $3.16 per share in cash and the right to participate in contingent milestone payments for each share of Esperion that they own. KSF is se.
May 04, 2026 | www.businesswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Esperion Therapeutics, Inc. (NASDAQ: ESPR)
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Esperion Therapeutics, Inc. (NASDAQ: ESPR ) related to its sale to funds managed by ARCHIMED. Under the terms of the proposed transaction, Esperion shareholders are expected to receive $3.16 per share in cash and the right to participate in contingent milestone payments. Is it a fair deal?
May 01, 2026 | www.globenewswire.com
Shareholder Alert: Ademi LLP investigates whether Esperion Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, May 1, 2026 /PRNewswire/ -- Ademi LLP is investigating Esperion (NASDAQ: ESPR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with ARCHIMED. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
May 01, 2026 | www.prnewswire.com
ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Esperion Therapeutics, Inc. (NASDAQ: ESPR) to funds managed by ARCHIMED for $3.16 per share in cash and the right to participate in contingent milestone payments. Halper Sadeh encourages Esperion shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.
May 01, 2026 | www.businesswire.com
Archimed to take Esperion Therapeutics private in $1.1 billion deal
Investment firm Archimed will ‌take Esperion Therapeutics private for up to $1.1 billion, the companies said on Friday, sending the drugmaker's shares up over 55% in ⁠premarket trading.
May 01, 2026 | www.reuters.com

Esper's Email Address Formats

Esper uses at least 1 format(s):

Esper Email Formats	Example	Percentage
First.Last@esper.com	John.Doe@esper.com	34%
FLast@esper.com	JDoe@esper.com	18%
First@esper.com	John@esper.com	14%
First.Last@esper.com	John.Doe@esper.com	34%

Frequently Asked Questions

Where is Esper's headquarters located?

Esper's main headquarters is located at 1006 West 31st Street Austin, Texas 78705 United States. The company has employees across 3 continents, including North AmericaAfricaAsia.

What is Esper's stock symbol?

Esper is a publicly traded company; the company's stock symbol is ESPR.

What is Esper's official website and social media links?

Esper's official website is esper.com and has social profiles on LinkedIn Crunchbase.

What is Esper's NAICS code?

Esper's NAICS code is 5112 - Software Publishers.

How many employees does Esper have currently?

As of April 2026, Esper has approximately 37 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Chief Revenue Officer: J. E.Chief Technology Officer: G. Z.Co-Founder & Ceo: M. M.. Explore Esper's employee directory with LeadIQ.

What industry does Esper belong to?

Esper operates in the Software Development industry.

What technology does Esper use?

Esper's tech stack includes CloudflareCircleCIZendesk ChatHubSpotPDF.jsCloudflare Bot ManagementHSTSZURB Foundation.

What is Esper's email format?

Esper's email format typically follows the pattern of First.Last@esper.com. Find more Esper email formats with LeadIQ.

When was Esper founded?

Esper was founded in 2018.

Esper

Q: What is Esper's official website and social media links?

Esper's official website is esper.com. Esper has social profiles on LinkedIn.

Q: How many employees does Esper have currently?

Esper has approximately 37 employees.

Q: What technology does Esper use?

Esper's tech stack includes LinkedIn, GoFundMe, Gradle, Rippling, TypeScript.

Q: What is Esper's NAICS code?

Esper's NAICS code is 5112 (Software Publishers).

Software DevelopmentTexas, United States11-50 Employees

Esper is empowering a new era of public administration with a platform that helps government evaluate and manage public policy. We partner with government to integrate and transform their data into actionable insights for more transparent, data-driven decision making.